Brazilian syringe and needle makers warned on Wednesday the country's coronavirus vaccination program was at risk after the government set auction prices too low and failed to draw bids for enough syringes to meet its requirements.
The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.
The scale of the Covid-19 outbreak in Wuhan early this year may have been nearly 10 times the recorded tally, a study conducted by China's public health authorities indicates, leaving the city where the coronavirus first took hold still well short of the immunity required to protect against a potential resurgence.
MPV Everest arrived in Hobart, Tasmania, on Wednesday to commence work for the Australian Antarctic Program, resupplying Australian stations and changing over personnel this summer.
The discovery of the ruins of old Roman baths during the construction of a major drainage system in the heart of Jordan's capital has posed a dilemma: how to preserve the country's ancient past while providing for its modern future?
Officials at the World Health Organization warned that the COVID-19 pandemic that has ravaged every corner of the world “is not necessarily the big one” — and that the novel coronavirus may never truly go away.
A new variant of the novel coronavirus does not appear to cause more severe illness than other variants, according to a matched study by Public Health England. Scientists say the new variant can spread more rapidity It was found in England in mid-December and led to other countries imposing travel restrictions to the United Kingdom. Several other countries have reported the variant.
British Prime Minister Boris Johnson has approved placing more parts of the country into tier 4 restrictions, as the country battles a new variant of Covid-19 which scientists say can spread more rapidly, The Times reported.
The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog’s Deputy Executive Director Noel Wathion said.
International arrivals fell by 72% over the first ten months of 2020, with restrictions on travel, low consumer confidence and a global struggle to contain the COVID-19 virus, all contributing to the worst year on record in the history of tourism.